An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran

Blood Transfusion

Volumn 11, Issue 2, 2013, Pages 233-240

  Mansouritorghabeh, Hassan ^a   Manavifar, Lida ^b   Banihashem, Abdollah ^c   Modaresi, Alireza ^c   Shirdel, Abbas ^b   Shahroudian, Masoud ^b   Shoja E Razavi, Ghazaleh ^b   Pousti, Hamid ^a   Esmaily, Habibollah ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Haemophilia a and b; North Eastern Iran; Platelet disorders; Rare bleeding disorders; Von Willebrand's disease

Indexed keywords

ADULT; AFIBRINOGENEMIA; AGED; ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CHILD; FEMALE; FIBRINOGEN DEFECT; HEALTH SURVEY; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INFANT; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRESCHOOL CHILD; SCHOOL CHILD; THROMBOCYTE DISORDER; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION DISORDERS, INHERITED; BLOOD COAGULATION FACTORS; BLOOD PLATELET DISORDERS; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGIC DISORDERS; HUMANS; INFANT; IRAN; MALE; MIDDLE AGED; VON WILLEBRAND DISEASES; YOUNG ADULT;

EID: 84876911385     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0023-12     Document Type: Article

References (25)

1. Stonebraker JS, Bolton-Maggs PHB, Soucie J, et al. A study of variations in the reported haemophilia A prevalence around the word. Haemophilia 2010;16:20-32.
2. El-Bostany EA, Omer N, Salama EE, et al. The spectrum of inherited bleeding disorders in pediatrics. Blood Coagul Fibrinolysis 2008;19:771-5.
3. Pinto MT, Ortiz Z. Haemophilia in developing world: success, frustrations and opportunities. Haemophilia 2004;10:14-9. (Pubitemid 40045414)
4. Nathwani AC, Tuddenham EGD. Epidemiology of coagulation disorders. Bailliere's Clin Haematol 1992;5:383-49.
5. O'Mahony B, Black C. Expanding hemophilia care in developing countries. Semin Thromb Hemost 2005;31:561-8. (Pubitemid 41642570)
6. Skinner MW. WFH - The cornerstone of global development: 45 years of progress. Haemophilia 2008;14:1-9. (Pubitemid 351722376)
7. Skinner MW. Building our global family-achieving treatment for all. Haemophilia 2010;16(Suppl. 5):1-10.
8. O'Mahony B. WFH: back to the future. Haemophilia 2004;10:1-8. (Pubitemid 40045412)
9. Mansouritorghabeh H, Rezaieyazdi Z, Pourfathollah AA, et al. Haemorrhagic symptoms in patients with combined factors V and VIII deficiency in north-eastern Iran. Haemophilia 2004;10:271-5. (Pubitemid 38584800)
10. Modaresi AR, Torghabeh MH, Pourfathollah AA, et al. Pattern of factor VIII inhibitor in patient with haemophilia A in the north east of Iran. Hematology 2006;11:215-7. (Pubitemid 44355705)
11. Mansouritorghabeh H, Pourfathollah AA, Rezaieyazdi Z. Coagulation therapy in hemophilia A and its relation with factor VIII inhibitor in northeastern Iran. Iranian J Med Sci 2004;29:199. (Pubitemid 40839615)
12. Mansouritorghabeh H, Pourfathollah AA, Mahmoodian Shooshtari M, Rezaieyazdi Z. First survey of factor IX inhibitor in northeastern Iran. Med J Islamic Rep Iran 2005;19:91-2.
13. Mansouritorghabeh H, Pourfathollah AA, Shooshtari M. Evaluation of the relationship between factor IX inhibitor in hemophilia B patients and different types of therapy in the north-eastern part of Iran. Iranian J Blood Cancer 2009;1:83-6.
14. Mansouritorghabeh H, Manavifar L, Mobalegh A, Shirdel A. Haemorrhagic manifestations and prevalence of factor V deficiency in north-eastern Iran. Haemophilia 2010;16:367-80.
15. Mansouritorghabeh H, Badiei Z, Noori F. Clinical pictures and prevalence of factor VII deficiency in Northeastern of Iran. Haemophilia 2008;14:157-9.
16. Mansouritorghabeh H, Rezaieyazdi Z, Pourfathollah AA. Combined factor V and VIII deficiency: a new family and their haemorrhagic manifestation. Haemophilia 2006;12:169-71.
17. Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia 2002;8:308-21. (Pubitemid 35277152)
18. Karimi M, Rahmani S, Ardeshiri R, Pasalar M. Health status in Iranian haemophilia patients. Haemophilia 2008;14:615-7. (Pubitemid 351638754)
19. Stonebraker JS, Brooker M, Amans RE, et al. A study of reported factor VIII use around the word. Haemophilia 2010;16:33-46.
20. Daliri AA, Haghparast H, Mamikhani J. Cost-effectiveness of prophylaxis against on demand treatment in boys with severe hemophilia A in Iran. Int J Technol Assess Health Care 2009;25:584-7.
21. Sirvastava A, Rodeghiero F. Epidemiology of von Willebrand disease in developing countries. Semin Thromb Hemost 2005;31:569-76. (Pubitemid 41642571)
22. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand, s disease. Blood 1987;69:545-9.
23. Karimi M, Yarmohammadi HI, Ardeshiri R, Yarmohammadi HO. Inherited coagulation disorders in southern Iran. Haemophilia 2002;8:740-4. (Pubitemid 35446625)
24. Ziaei JE, Dolatkhah R, Dastgiri S, et al. Inherited coagulation disorders in the northwestern region of Iran. Haemophilia 2005;11:424-6. (Pubitemid 41030850)
25. Mehdizadeh M, Kardoost M, Baghaeepour MR, et al. Occurrence of haemophilia in Iran. Haemophilia 2009;15:348-51.